New study aims to unlock immune secrets of b-cell cancers
NCT ID NCT07515313
First seen Apr 15, 2026 · Last updated May 17, 2026 · Updated 1 time
Summary
This study will measure two immune system markers, CD274 and CD276, in blood and bone marrow samples from 159 people newly diagnosed with B-cell cancers like leukemia and lymphoma. The goal is to see if these markers can help doctors better diagnose these cancers and understand why some don't respond to treatment. Participants will provide samples before starting chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B CELL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.